myHSteam

First of all, the fact that you're being proactive and exploring your options is a really positive step — and yes, there is genuine hope here! 🌟

While complete remission rates vary depending on the treatment and the individual, there is promising data from recent clinical trials on biologics for moderate to severe HS Show Full Answer

First of all, the fact that you're being proactive and exploring your options is a really positive step — and yes, there is genuine hope here! 🌟

While complete remission rates vary depending on the treatment and the individual, there is promising data from recent clinical trials on biologics for moderate to severe HS (which includes stage 3).

Here's what one study on an investigational biologic called sonelokimab found after 40 weeks:

- 62% of participants achieved at least 75% skin clearance
- Up to 32% reached complete skin clearance
- Up to 25% achieved inflammatory remission, meaning no detectable abscesses, nodules, or draining tunnels
- Up to 43% experienced significant improvement in their worst skin pain It's also worth knowing that biologics already approved by the FDA for HS — like Humira, Bimzelx, and Cosentyx — have also shown meaningful results for people with severe HS.

One important thing to keep in mind: biologics can take up to three months to show their full effects, so patience is key once you start.

The data is genuinely encouraging, especially for stage 3. Hang in there — starting biologics could be a real turning point for you. 💙

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

75% HS Skin Clearance Achieved by 62% of People After 40 Weeks on Sonelokimab

Treatments for Hidradenitis Suppurativa